#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mastocytosis Acute respiratory distress syndrome Myxofibrosarcoma Neuropathy peripheral Glioma Pancreatic carcinoma metastatic Hodgkin's disease Cervix carcinoma recurrent Staphylococcal infection Bladder cancer Arterial disorder Ependymoma Acute lymphocytic leukaemia recurrent Oesophageal achalasia Blood iron increased More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Treatment Cystic fibrosis lung – Life with Disease Langerhans’ cell histiocytosis – Treatment Acquired haemophilia – Life with Disease Haemolytic uraemic syndrome – Diagnostics Andersen-Tawil syndrome – Trials in Disease Primary mediastinal large B-cell lymphoma – Treatment Angiosarcoma recurrent – Diagnostics Mantle cell lymphoma stage III – Diagnostics Gastrointestinal stromal tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    For-6219 Fulvestrant Elezanumab Flucloxacillin Hdp-101 Fezolinetant LYSERGIDE VINBLASTINE Carboplatin Dexamethasone Sodium Phosphate TTX-381 Pseudoephedrine Hydrochloride D5-Ethyl-Beta-D-Glucuronide Hydrocortisone Fostemsavir PICLIDENOSON Vrdn-001 Bedaquiline Dicloxacillin Botulinum Toxin Type A More therapies…

    Learn about Your Condition

    Migraine with aura Bronchitis Gingival bleeding Staphylococcal bacteraemia Thrombocytopenia H1N1 influenza Breast cancer recurrent Diabetic ketoacidosis Lung neoplasm malignant Optic atrophy Endometrial cancer stage I Cerebrovascular accident Anogenital warts Femur fracture Heparin resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effect of Metyrapone on Heart Health in Patients with Adrenal Tumors and Mild Cushing’s Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metyrapone
    Italy

  • Study on Cisplatin, Nab-paclitaxel, and Nivolumab with Radiotherapy for Patients with Non-Metastatic Muscle Invasive Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Cisplatin
    • Nivolumab
    • Paclitaxel Albumin-Bound
    Italy

  • Study on the Effectiveness of Paclitaxel and Gemcitabine for Patients with Pancreatic Cancer Spread to the Abdomen

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel
    Italy

  • Study on 68Ga-FAPI-46 PET/CT for Cancer Patients with Unclear Results from 18F-FDG PET/CT

    Recruiting

    2 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Italy

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Cefotaxime Sodium
    • Cefuroxime Sodium
    • Gentamicin
    Austria

  • Study of Datopotamab Deruxtecan for Patients with Triple-Negative Breast Cancer and New or Worsening Brain Metastases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    Austria Ireland
Previous Page
1 … 293 294 295 296 297 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!